Nuformix PLC AGM Results (8767L)
10 Septiembre 2019 - 10:49AM
UK Regulatory
TIDMNFX
RNS Number : 8767L
Nuformix PLC
10 September 2019
10th September 2019
Nuformix plc
("Nuformix" or "the Group"),
Result of Annual General Meeting
The Annual General Meeting of Nuformix plc was held on 10(th)
September 2019 at 1.00pm, at the offices of Shakespeare Martineau
LLP, 60 Gracechurch Street, London, EC3V 0HR.
As announced this morning resolution 7 was withdrawn from the
meeting. The Directors of the Company wish to announce that all
other resolutions put to shareholders were duly passed and approved
on a show of hands at the meeting. The results of the proxy voting
position received in advance of the meeting are reported below:
Resolution Ordinary/ For Against Total votes
Special cast
No. of % No. of %
votes votes
To receive the annual
report and accounts
for the year ended
1 31 March 2019 Ordinary 121,471,999 100 0 0 121,471,999
To approve the Annual
2 Report on Remuneration Ordinary 121,413,979 100 0 0 121,413,979
To re-appoint David
3 Tapolczay as a director Ordinary 121,465,547 100 0 0 121,465,547
To re-appoint Daniel
4 Gooding as a director Ordinary 121,471,999 100 0 0 121,471,999
To re-appoint Joanne
5 Holland as a director Ordinary 121,465,547 100 0 0 121,465,547
To re-appoint John
6 Lidgey as a director Ordinary 83,841,906 99.85 123,641 0.15 83,965,547
7 To re-appoint Kirk Ordinary Withdrawn
Siderman-Wolter
as a director
To re-Christopher
8 Blackwell as a director Ordinary 121,465,547 100 0 0 121,465,547
To re-appoint haysmacintyre
9 as auditor Ordinary 121,465,547 100 0 0 121,465,547
To authorise the
Directors to determine
10 the auditor's fees. Ordinary 121,465,547 100 0 0 121,465,547
To authorise the
Directors to allot
11 shares. Ordinary 121,471,999 100 0 0 121,471,999
To authorise the
Directors to disapply
12 pre-emption rights. Special 121,465,547 100 0 0 121,465,547
To authorise the
Company to purchase
13 its own shares. Special 121,471,999 100 0 0 121,471,999
To authorise calling
of a general meeting
on 14 clear days'
14 notice. Special 121,471,999 100 0 0 121,471,999
A vote withheld is not a vote in law and is not counted in the
calculation of votes validly cast for or against a resolution.
The Company's issued share capital is 469,466,512 ordinary
shares of GBP0.001 each. Copies of the resolutions passed as
special resolutions at the AGM will shortly be available for
inspection at the National Storage Mechanism, which is located at:
http://www.morningstar.co.uk/uk/nsm.
Enquiries:
Nuformix plc
Dr Dan Gooding, Chief Executive
Officer +44 (0)1223 423667
Optimum Strategic Communications
Mary Clark, Supriya Mathur +44 (0) 203 950
Email: nuformix@optimumcomms.com 9144
About Nuformix plc: www.nuformix.com
Nuformix is a pharmaceutical development company using cocrystal
technology to unlock the therapeutic potential of approved small
molecule drugs. Nuformix's risk-mitigated development strategy has
resulted in a pipeline of discoveries through which it has
developed and patented novel cocrystal forms of approved small
molecules.
Nuformix has created an IP portfolio of granted patents covering
cocrystal forms of five small molecule drugs. Nuformix is targeting
high-value unmet needs with its lead programmes in oncology
supportive care: NXP001 and fibrosis: NXP002.
Nuformix was established in Cambridge in 2009 and has invested
in pharmaceutical cocrystal R&D, establishing world-class
capability and know-how in cocrystal discovery and development,
yielding multiple product opportunities.
Nuformix plc shares are traded on the London Stock Exchange's
Official List under the ticker: NFX.L.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGLLFSEADIILIA
(END) Dow Jones Newswires
September 10, 2019 11:49 ET (15:49 GMT)
Nuformix (LSE:NFX)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Nuformix (LSE:NFX)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024